Cyclin-dependent kinase 4 drives cystic kidney disease in the absence of mTORC1 signaling activity
Kidney International · 2024
DOI: 10.1016/j.kint.2024.08.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney International, 2024. Verfasst von Florian Grahammer und 18 weiteren Autor:innen. Beteiligte Einrichtung: III. Department of Medicine, University Hospital Hamburg Eppendorf, Hamburg, Germany; Hamburg Center for Kidney Health (HCKH), University Medical Cen…. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase 4, Kinesins, Mechanistic Target of Rapamycin Complex 1, Signal Transduction. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Progression of cystic kidney disease has been linked to activation of the mTORC1 signaling pathway. Yet the utility of mTORC1 inhibitors to treat patients with polycystic kidney disease remains controversial despite promising preclinical data. To define the cell intrinsic role of mTORC1 for cyst development, the mTORC1 subunit gene Raptor was selectively inactivated in kidney tubular cells lacking cilia due to simultaneous deletion of the kinesin family member gene Kif3A. In contrast to a rapid onset of cyst formation and kidney failure in mice with defective ciliogenesis, both kidney function, cyst formation discerned by magnetic resonance imaging and overall survival were strikingly improved in mice additionally lacking Raptor. However, these mice eventually succumbed to cystic kidney disease despite mTORC1 inactivation. In-depth transcriptome analysis revealed the rapid activation of other growth-promoting signaling pathways, overriding the effects of mTORC1 deletion and identified cyclin-dependent kinase (CDK) 4 as an alternate driver of cyst growth. Additional inhibition of CDK4-dependent signaling by the CDK4/6 inhibitor Palbociclib markedly slowed disease progression in mice and human organoid models of polycystic kidney disease and potentiated the effects of mTORC1 deletion/inhibition. Our findings indicate that cystic kidneys rapidly adopt bypass mechanisms typically observed in drug resistant cancers. Thus, future clinical trials need to consider combinatorial or sequential therapies to improve therapeutic efficacy in patients with cystic kidney disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- III. Department of Medicine, University Hospital Hamburg Eppendorf, Hamburg, Germany; Hamburg Center for Kidney Health (HCKH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: f.grahamm…
- III. Department of Medicine, University Hospital Hamburg Eppendorf, Hamburg, Germany; Hamburg Center for Kidney Health (HCKH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Division of Nephrology, University of Washington School of Medicine, Seattle, Washington, USA; Kidney Research Institute, University of Washington School of Medicine, Seattle, Washington, USA; Institute for Stem Cell an…
- Institute of Experimental Medicine and Systems Biology, Medical Faculty, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University, Aachen, Germany.
- Department of Electrical Engineering and Information Technology, Technische Universität Darmstadt, Darmstadt, Germany.
- Department of Medicine IV, Medical Center and Faculty of Medicine University of Freiburg, Freiburg, Germany.
Förderung
- NIDDK NIH HHS
- NCATS NIH HHS
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Grahammer, F., Dumoulin, B., Gulieva, R. E., Wu, H., Xu, Y., Sulaimanov, N., Arnold, F., Sandner, L., Cordts, T., Todkar, A., Moulin, P., Reichardt, W., Puelles, V. G., Kramann, R., Freedman, B. S., Busch, H., Boerries, M., Walz, G., & Huber, T. B. (2024). Cyclin-dependent kinase 4 drives cystic kidney disease in the absence of mTORC1 signaling activity. Kidney International. https://doi.org/10.1016/j.kint.2024.08.021
Vancouver
Grahammer F, Dumoulin B, Gulieva RE, Wu H, Xu Y, Sulaimanov N, et al. Cyclin-dependent kinase 4 drives cystic kidney disease in the absence of mTORC1 signaling activity. Kidney International. 2024. doi:10.1016/j.kint.2024.08.021
BibTeX
@article{Grahammer2024,
author = {Grahammer, Florian and Dumoulin, Bernhard and Gulieva, Ramila E and Wu, Hui and Xu, Yaoxian and Sulaimanov, Nurgazy and Arnold, Frederic and Sandner, Lukas and Cordts, Tomke and Todkar, Abhijeet and Moulin, Pierre and Reichardt, Wilfried and Puelles, Victor G and Kramann, Rafael and Freedman, Benjamin S and Busch, Hauke and Boerries, Melanie and Walz, Gerd and Huber, Tobias B},
title = {Cyclin-dependent kinase 4 drives cystic kidney disease in the absence of mTORC1 signaling activity},
journal = {Kidney International},
year = {2024},
doi = {10.1016/j.kint.2024.08.021}
}
EUVIMED